Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.WT | TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by Rumpl3StiltSkinon Oct 03, 2022 10:36am
138 Views
Post# 35001433

RE:Near term impact on price

RE:Near term impact on price
DJDawg wrote:
Am I correct that the buyers of this new block of shares won't be able to sell for 4 months like the previous PP that was just announced. If so then it doesn't great new shares that will suddenly appear on the market. I guess it takes away some of the incentive for people to buy at current price as they can get some of these new shares plus a warrant.

Am I correct that people think it won't change too much and the price will hang out around the current level for a while till the next clinical trial announcement of some kind?

I like that it will give RDW enough cash that if he start some JV negotiation it won't be from an apparent position of desparation and low cash.

Thoughts?


I think this is already priced in. No one is selling. If you aren't already in on this deal then you have to buy at market. The market is priced higher than the PP... Very nice, IMO.

<< Previous
Bullboard Posts
Next >>